Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Tumor Suppressor Genes Folder Title: Suppress Updated: April 5, 2007 TtlOffGn Genetic Aberrations in Cancer: What Can Go Wrong? Inherent or Induced Initial non-Random Genetic Instability Progressive Random Genetic Instability Point Mutations and Failure to Repair DNA Translocations and Inversions of Chromosomal Material • To Where? • Next to What? Activated?, Repressed? Amplified? • Fused to What? Mis-regulated? Deletions • Of Entire Chromosomes • Of Parts of Chromosomes • Of Specific Genes Additions • Aberrant Chromosome Replication: Trisomy & Aneuploidy • Amplifications and Repeats GoWrong Specific Genetic Abnormalities Associated with Specific Cancers Chronic Myelogenous Leukemia Reciprocal Translocation, 9&22 Burkitt's Lymphoma Reciprocal Translocation, 8&14 Myelodysplasia and Acute Myelogenous Leukemia Trisomy 8 Meningioma Monosomy 22 SpecCx Chromosomal Deletions Associated with Specific Neoplasms 1p Melanoma, Neuroblastoma, Thyroid Cx, Ductal Breast Cx Multiple Endocrine Neoplasia Breast Carcinoma Small-cell Lung Cx, Renal Cell Cx, Cervical Cx Familial Polyposis Coli, Colorectal Cx Wilm's Kidney Tumor, Breast Cx, Rhabodmyosarcoma, Bladder Cx Retinoblastoma, Osteogenic Sarcoma Small-cell Ling Cx, Ductal Breast Cx Small-cell Lung Cx, Colorectal Cx, Breast Cx, Osteosarcoma Neurofibroma Colorectal Cx Menigioma, Acoustic neuroma, Pheochromocytoma 1q 3p 5q 11q 13q 17p 17q 18q 22 From: JNCI, 83:92 (1991) GenLost1 Oncogenes & Cancer: Some Uncomfortable Facts & Questions (Part 1) • Some cancers involve loss of chromosomes, loss of heterozygosity, loss of genes. • How can losing an oncogene cause a cancer? OncProb1 Oncogenes & Cancer: Some Uncomfortable Facts & Questions (Part 2) • If a malignant cell is fused with a normal non-malignant cell, the hybrid cell is often non-malignant. • How can the malignant phenotype be recessive in the cancer cell, if malignancy is caused by the presence of an oncogene? OncProb2 Oncogenes & Cancer: Some Uncomfortable Facts & Questions (Part 3) • Pre-disposition to some cancers is heritable in a Mendelian dominant manner. • If an oncogene causing cancer is being inherited in the germ line, wouldn't that be a lethal in the developing fetus? See Sidebar 7.5, p. 226 in Weinberg OncProb3 Oncgenes & Cancer: Uncomfortable Facts & Questions (Part 4) • About 15 to 30% of human cancers are associated with oncogene expression. • What is the genetic basis for the other human cancers? OncProb4 Oncogenes & Cancer: Some Uncomfortable Facts & Questions (Part 5) • In spite of constant cell-division throughout life, "only" one person in four presents with a cancer during their life-time. • If cancers are caused by turning on one of thirty or forty oncogenes, why aren't there more cancers? OncProb5 The Likely Answer: From Harris and Knudsen Some cancers must be associated with loss of genetic functions. • There must be genes and gene products that normally prevent cancer from being expressed. • There must be tumor suppressor genes and tumor suppressor proteins. MustStop Genetic Aberrations in Cancer: What Genes are Messed Up? What gene has been mutated, amplified, derepressed, activated, fused and mis-regulated, repeated? What is it product, and what does that product normally do? CancerGenes or Oncogenes What gene has been inactivated, repressed, lost? What is its product, and what does that product normally do? Suppressor Genes or Anti-Oncogenes WhoWrong Chromosomal Deletions Associated with Specific Neoplasms What's Missing? 1p 1q 3p 5q 11q APC* WT1 13q Rb1 17p p53 17q 18q 22 NF1 DCC Melanoma, Neuroblastoma, Thyroid Cx, Ductal Breast Cx Multiple Endocrine Neoplasia Breast Carcinoma Small-cell Lung Cx, Renal Cell Cx, Cervical Cx Familial Polyposis Coli, Colorectal Cx Wilm's Kidney Tumor, Breast Cx, Rhabodmyosarcoma, Bladder Cx Retinoblastoma, Osteogenic Sarcoma Small-cell Ling Cx, Ductal Breast Cx Small-cell Lung Cx, Colorectal Cx, Breast Cx, Osteosarcoma Neurofibroma Colorectal Cx Menigioma, Acoustic neuroma, Pheochromocytoma From: JNCI, 83:92 (1991) * Added 2003 GenLost2 Proposed Role for APC Protein in Mitosis APCMitosis Familial Adenomatous Polyposis Coli Figure 7.22 The Biology of Cancer (© Garland Science 2007) p. 226 Figure 7.10 The Biology of Cancer (© Garland Science 2007) p. 219 Figure 7.6 The Biology of Cancer (© Garland Science 2007) p. 216 Figure 7.5a The Biology of Cancer (© Garland Science 2007) p. 215 Properties and Functions of the Rb1 Gene Product: pRB 105 Kd Nuclear Phospho-protein • Hypo-phosphorylated: Binds E2F Transcription Factor Represses Cell Cycle • Hyper-phosphorylated: Releases E2F Transcription Factor Releases Cell into Cycle Phosphorylated by Cyclin-dependent Kinase (CDK) pRBdoes1 Cell Cycle Control by Onco-Proteins Figure 5-5, McKinnell, p. 148 Blocking pRB Function Complete Deletion of Both Copies of RB1 Gene in Transformed Cell Lineage • Two Events in a Normal Somatic Cell • One Event in Dominantly-Inherited RB1 Gene Loss in Germ Line Point Mutations • Affecting E2F Binding Sites • Affecting Phosphorylation Sites Blocking of E2F Binding Site by Viral Oncoproteins • SV40 Large T-Antigen • E1A Adenovirus Oncoprotein • E7 Papilloma Virus Oncoprotein pRBBlock Figure 8.21a The Biology of Cancer (© Garland Science 2007) p. 276 RB Deletions and Mutations: Germ-line vs Somatic Germ-Line First Hit RB Deletions • Familial, Bilateral Retinoblastoma • Osteogenic Sarcoma • Why These lineages and not all other cell types? • Alternative Pathways (Redundancy) in Cell Cycle Regulation? Somatic Point Mutations or Deletions: Two Hits per Cell • Bladder Cancers (33% associated) • Small Cell Lung Cancer (SCLC): (60% Associated) • Breast Cancers (33% Associated) • Prostatic, Cervical Cancers, Some Leukemias • Sporadic Association RBCxs Restoring pRB Function RB- Cell From Retinoblastoma, Osteogeneic Sarcoma, Bladder Carcinoma, or Prostate Cancer Insert Normal Rb1Gene by Microcell Transfer Restoration of Normal Phenotype: • Morphological Reversion to Normal • Normal Growth Rate • Loss of Growth in Soft Agar • Loss of Tumorigenicity in Nude Mice RBReturn p53 Tumor Suppressor Protein 53 Kd Protein Attached to SV40 Large TAg Transformed and Immortalized Transfected Cells Found in many human and murine tumors and neoplastic cell lines All were mutant variants of a tumor suppressor protein. Germ-line Mutations in Li-Fraumeni sydrome affecting one p53 Gene allele: Predispose to early onset osteogenic sarcoma, adrenocortical carcinomas, breast carcinomas, or brain cancers p53Found Normal Role of p53 Protein • Localize in Nucleus. • Transcription Factor Controlling Cell- replication associated genes • Anti-proliferative and Anti-neoplastic: Prevents cells with damaged DNA from entering the cell cycle • Promotes Apoptosis in Cells with DNA Irreparably Damaged • Can bind to and down-regulate the bcl-2 apoptosis-blocking gene product p53Role Mutant or Deleted p53 in Clinical Human Cancers 50 to 60% of Human Cancers Show Mutations, Deletions, or Abberant Expression Involving p53 Almost every histogenetic type: bladder, bone, brain, breast cervix, colon, esophagus, hematopoietic larynx, liver, lung, lymphoid tissue, malignant melanoma ovary, pancreas, prostate, skin, stomach thyroid, uterine endometrium p53 Expression can be used prognostically p53inCxs Oncogenes Compared to Suppressor Genes (from Ruddon, 3rd Ed., Table 8-3, p.320) Oncogenes One Mutational Event Dominant Gain of Function Not in Germ Line Somatic Mutations: Yes Activate Cell Growth Gene Transfection: Can Transform NIH3T3 Cells Genetic Alterations: Gene Rearrangements Point Mutations Gene Amplification Suppressors Two Mutational Events Recessive Loss of Function Heritable in Germ Line Somatic Mutations: Yes Inhibit Cell Growth Gene Transfection: Suppress Malignant Phenotype Genetic Alterations: Deletions Point Mutations OncvStop